Sunday, August 14, 2005
Just kidding.

I posted yesterday while I had a little freak out, and deleted it immediately when I calmed down. I realized I was being irrational, so forgive me if it was seen by anyone.

Is there a reason besides excitement for preggo neighbor #1 to be trying on maternity clothes at eight weeks? I mean how many safety pins is she going to put on those things before she realizes there is no belly to hold them up yet? It just looks tacky.

Speaking of being pregnant, I am not. (confirmed by three pregnancy tests on three different days) Yet my monthly thing is very ellusive this month. Maybe it's the meds? It looks like a doctors visit is in the mix.

Anyone want to guess the kid per adult ratio it takes to have one house torn apart in less than three minutes? 3:1. That's right, six kids under four can do it in THREE MINUTES with the supervision of two adults.

We added some new pets to the already overfilled household. These are possibly temporary. We now have seven toads. They live on the table outside my front door. We've been feeding them worms and ants for the last week, and they have almost doubled in size. The girls love them. LOVE THEM. They even try to catch bugs so they can feed them.

I've been getting sick every day for four days. It happens exactly three minutes after we put the girls to bed. (Hence the three pee-sticks taken) I don't think this is the meds, as it is so recent. Yuck.

My life is boring, but mostly I am content.

Blogger Heidi had this to say:

Oh, man! I missed a freak out post!!?!?!?! Bummer! ;)

sorry to hear about the pukes and elusive visit from Aunt Flo. hope you have some answers soon...

I was surprised to read about your pet toads. we have had some similar new pets here at our new house... a little family of frogs have been living in our in-ground pool, and the girls love them! Matt dived into the deep end and caught them so the girls could put them in their yellow pail and admire them. I took some pics and plan to post them whenever my hubby has the time to help me figure out how to do it... :)

11:28 PM EDT 

Blogger philharolds6425 had this to say:

Hot Stock For Your Review!!

+++++++++++Current Profile+++++++++++

Faceprint Global Solutions (FCPG)

Current Price $0.15

A company with hot new identity solution products

and licenses with over 40 current governmental and

non-governmental contracts in negotiations.


FCPG is now offering the world's leading encryption software to IBM's North American clients.

Will It Still Go Higher?

Does It Sound New and Exciting To You?

Please Review Exactly What this Company Does.


Faceprint Global Solutions (FCPG) is pleased to announce that its European partner, Keyvelop, has teamed up with IBM's Partner World Industry Networks to deliver customer software requirement solutions for the international healthcare industry.

With FCPG owning the exclusive North American rights to distribute the worlds leading encryption and transmission software developed by Keyvelop, FCPG is poised to capture large volumes of sales generated by customers currently using IBM's software in the healthcare and other industries.

With traceability and security now deemed a serious business priority, companies are increasingly focused on employing procedures and controls designed to ensure the authenticity, integrity and confidentiality of electronic records.

\"This is a very positive move for FCPG and for Keyvelop,\" said FCPG CEO Pierre Cote. \"We are very happy about the decision to go with IBM. This is a continuation of the progress made by everyone associated with FCPG and its partners.\"

Buell Duncan, IBM's general manager of ISV & Developer Relations commented, \"Collaborating with Keyvelop will ensure that we develop open solutions that are easy to maintain and cost effective for our customers in the healthcare and life sciences industry.\"

Among other things, this new software technology which is currently being used by a number of European healthcare companies, is used to send any file, regardless of format or size. Encryption keys, evidence of transmission integrity with fingerprint calculation, time-stamping of all actions and status record updating, pre-checking sender and receiver identities, validating file opening dates are part of Keyvelop features.

About FacePrint Global Solutions, Inc.

FCPG operates a business, which develops and delivers a variety of technology solutions, including biometric software applications on smart cards and other support mediums (apometric solutions). FCPG's products provide biometric solutions for identity authentication and a host of smart card- and biometrics-related hardware peripherals and software applications. Apometrix, FCPG's wholly-owned subsidiary, combines on-card or in-chip multi-application management solutions with best-of-breed 'in-card matching' biometrics. Keyvelop's secure digital envelope solution and Apometrix's on-card biometrics work together to produce the winning combination in the fields of security, traceability and identity management.


The examples above show the Awesome, Earning Potential of little known Companies That Explode onto Investor's Radar Screens. This stock will not be a Secret for long. Then You May Feel the Desire to Act Right Now! And Please Watch This One Trade!


All statements made are our express opinion only and should be treated as such. We may own, take position and sell any securities mentioned at any time. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be \"forward looking statements.\" Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. This profile is in no way affiliated with the featured company. We were compensated one thousand dollars from third party (IR Marketing) to distribute this report. Forward looking statements in this action may be identified through the use of words such as: \"projects\", \"foresee\", \"expects\". in compliance with Section 17(b), we disclose the holding of FGS shares prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. Since we own shares, there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward-looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties that could cause results to differ materially from those set forth in the forward- looking statements. This is not solicitation to buy or sell stocks, this text is for informational purpose only and you should seek professional advice from registered financial advisor before you do anything related with buying or selling stocks, penny stocks are very high risk and you can lose your entire investment.

3:37 PM EDT 

Anonymous Anonymous had this to say:

That's a great story. Waiting for more. »

2:01 PM EST 

Anonymous Anonymous had this to say:

Cool blog, interesting information... Keep it UP seroquel affects Vitamin e study free side effects seroquel Utah topamax weight loss Protonix descripton Hot coed lesbian Wexler skin care review how to make your own automatic gate opener alaska bextra side effects Seroquel depression med taking seroquel with abilify Wholesale pda Yasmin walji seroquel in schools Human medications and dogs Side effects of zoloft and effexor Baccarat playing strategy Seroquel abilify &aposside effects Boston in tooth whitening toys are us

8:05 AM EST 

Anonymous Anonymous had this to say:

Where did you find it? Interesting read film editing schools

8:26 AM EDT 

Post a Comment

Back To the Main Page